Abstract
The cognitive goal of every science is to establish causal links between phenomena. Medicine aims first and foremost at discovering the origins of diseases. Certainly, there is a general approach manner, but the development of this science in the last forty years has pertinently shown that the optimal method depends on the disease’s own nature. For instance, chronic diseases which dramatically irrupted in human pathology in the postwar period have imposed the surge and progression of a new epidemiology which completes the clinic and the experimental laboratory as places for the study of an illness. Its object is the community, not the individual or the laboratory animal. The field where it picks up the phenomena and their interrelations is much wider and therefore much wider are the possibilities of detecting two fundamental links beween phenomena: those of simultaneity and of successiveness. The cross section epidemiology looks for simultaneity relations, the prospective one for succession links. The concept of “risk factor” implies a succession link. Epidemiology operates with observations that is with postures in which the research worker is passive. As a matter of fact beyond every phenomenon stands an “intervention”, because nothing can occur without an intervention. This truth lies on the bedrock of the central metaphor of epidemiology: “nature experiments”.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kaplan N. Mass control of coronary risk factors. The Lancet II (1983) 406
Kornitzer M. De Baker G. Dramaix M., et al: Belgian heart disease prevention project: Incidence and Mortality Results. The Lancet I (1983) 1066–1070
Oliver M. F.: Does control of risk factors prevent coronary heart disease? Brit. Med. J. 285 (1982) 1065–1066
Puska P., Tuomilehto J., Salonen J. et al: Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North-Karelia Project). Brit. Med. J. 2 (1979) 1173–1178
Rose G., Tunstall-Pedoe H. D., Heller R. F.: UK heart disease prevention project: incidence and mortality results. The Lancet I (1983) 1062–1066
Steinbach M.: The methodology of intervention trials. In: Atherosklerosis III, Proceedings of the Third International Symposium, Springer Verlag, Berlin-Heidelberg-New York 1974, 720–723
Steinbach M., Constantineanu M., Georgescu M., et al:The Bucharest Multifactorial Prevention Trial of Coronary Heart Disease — Ten Year Follow-up: 1971–1982: Rev. Roum. Med. — Med. Int., 22 (1984) 99–106
Williams P. T., Fortmann S. P., Farqumar J. W. et al: A comparison of statistical methods for evaluating risk factor changes in community — based studies: an example from the Stanford Three Community Study. J. Chron. Dis. 34 (1981) 565–571
An International Controlled Trial in the Multifactorial Prevention of Coronary Heart Disease. World Health Organization, European Collaborative Group. Int. J. Epidemiol. 3 (1974) 219–224
Multiple Risk Factor Intervention Trial. Risk Factor Changes and Mortality Results. Multiple Risk Factor Intervention Trial Research Group. J. A. M. A. 24 (1982) 1465–1477
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Steinbach, M. (1985). The Dilemma of Prevention Trials. In: Jesdinsky, H.J., Trampisch, H.J. (eds) Prognose- und Entscheidungsfindung in der Medizin. Medizinische Informatik und Statistik, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82651-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-82651-1_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16068-7
Online ISBN: 978-3-642-82651-1
eBook Packages: Springer Book Archive